Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma-Reference-Cited by-同舟云学术

Versican Promotes Tumor Progression, Metastasis and Predicts Poor Prognosis in Renal Carcinoma

Published:2017-02-27 Issue:7 Volume:15 Page:884-895
ISSN:1541-7786
Container-title:Molecular Cancer Research
language:en
Short-container-title:Mol Cancer Res

Author:

Mitsui Yozo,Shiina Hiroaki,Kato Taku,Maekawa Shigekatsu,Hashimoto Yutaka,Shiina Marisa,Imai-Sumida Mitsuho,Kulkarni Priyanka,Dasgupta Pritha,Wong Ryan Kenji,Hiraki Miho,Arichi Naoko,Fukuhara Shinichiro,Yamamura Soichiro,Majid Shahana,Saini Sharanjot,Deng Guoren,Dahiya Rajvir,Nakajima Koichi,Tanaka Yuichiro

Funder

National Cancer Institute

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology,Molecular Biology

Cited by 64 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revealing the crucial roles of suppressive immune microenvironment in cardiac myxoma progression;Signal Transduction and Targeted Therapy;2024-08-02

2. The Origin of Patient-Derived Cancer Organoids from Pathologically Undiagnosed Specimen in Patients with Pancreatobiliary Cancers;2024-07-03

3. Dissecting gastric cancer heterogeneity and exploring therapeutic strategies using bulk and single-cell transcriptomic analysis and experimental validation of tumor microenvironment and metabolic interplay;Frontiers in Pharmacology;2024-06-19

4. Altered extracellular matrix correlates with an immunosuppressive tumor microenvironment and disease progression in younger adults with oral cavity squamous cell carcinoma;Frontiers in Oncology;2024-06-18

5. GALNT2 targeted by miR-139-5p promotes proliferation of clear cell renal cell carcinoma via inhibition of LATS2 activation;Discover Oncology;2024-03-13